| Patient | Jim Thorpe |
|---|---|
| Date of birth | 1888-05-28 |
| Identifiers | MRN HR-ML011-SYN-TD; SSN (made up) 000-11-9036 |
| Document date | 1951-07-13 |
| Author | Nolan Fairbanks, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Two weeks after excision of the lip cancer: pathology, wound check, surveillance plan, lipids, and cardiac rehabilitation. [S]
Mr. Thorpe returns two weeks after V-excision of the lower lip cancer by Dr. Ferrante. The CT of the neck before surgery showed no enlarged or abnormal lymph nodes. He took acetaminophen for three days after the operation and needed nothing stronger. The stitches were removed last week. His lip feels a little tight but he can whistle, drink from a cup and speak clearly. He has had no chest tightness since the first week of his medicines and has not used nitroglycerin. He took aspirin throughout and had only slight oozing on the first night. He is keen to start cardiac rehabilitation. [S]
| Element | Detail |
|---|---|
| Surgery | V-excision two weeks ago; stitches out; lip function normal |
| Neck CT before surgery | No enlarged or abnormal lymph nodes |
| Angina | None for four weeks |
| Medicines | Aspirin, atorvastatin 80 mg and metoprolol taken daily |
| System | Result | Finding |
|---|---|---|
| Ears, nose, mouth, and throat | Positive | Lip slightly tight; no pain, drooling, or trouble eating |
| Cardiovascular | Negative | No chest tightness, palpitations, or leg swelling |
| Musculoskeletal | Negative | No muscle aches on atorvastatin |
| Neurological | Negative | Lip sensation normal |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Aspirin 81 mg delayed-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1951-06-08 | active | S |
| Atorvastatin 80 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1951-06-08 | active | S |
| Metoprolol succinate 25 mg extended-release oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1951-06-08 | active | S |
| Nitroglycerin 0.4 mg sublingual tablet, one tablet under the tongue for chest pain, repeated every 5 minutes up to 3 tablets | One tablet under the tongue as needed for chest pain; call 911 if pain persists 5 minutes after the first tablet | Sublingual route | 1951-06-08 | active | S |
| Ezetimibe 10 mg oral tablet, one tablet by mouth daily | One tablet by mouth daily | Oral route | 1951-07-13 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 1951-07-13 | Body height | 185 | cm | S |
| 1951-07-13 | Body weight | 93 | kg | S |
| 1951-07-13 | Body mass index (BMI) [Ratio] | 27.2 | kg/m2 | S |
| 1951-07-13 | Systolic blood pressure | 128 | mm[Hg] | S |
| 1951-07-13 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 1951-07-13 | Heart rate | 62 | /min | S |
| 1951-07-13 | Respiratory rate | 14 | /min | S |
| 1951-07-13 | Body temperature | 36.6 | Cel | S |
| 1951-07-13 | Oxygen saturation in Arterial blood by Pulse oximetry | 97 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 1951-07-13 | Cholesterol [Mass/volume] in Serum or Plasma | 136 | mg/dL | <=199 mg/dL | Normal | S |
| 1951-07-13 | Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation | 68 | mg/dL | Below 100 mg/dL in general; secondary-prevention goal below 55 mg/dL | Normal | S |
| 1951-07-13 | Cholesterol in HDL [Mass/volume] in Serum or Plasma | 42 | mg/dL | >=40 mg/dL | Normal | S |
| 1951-07-13 | Triglyceride [Mass/volume] in Serum or Plasma | 130 | mg/dL | <=149 mg/dL | Normal | S |
| 1951-07-13 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 31 | U/L | 7-55 U/L | Normal | S |
Vital signs recorded on 1951-07-13; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well; blood pressure 128/78, pulse 62; weight 93.0 kg |
| Head and neck | Lower lip scar healing well, vermilion line aligned; good lip closure; no nodularity; mouth normal; no neck nodes |
| Cardiovascular | Regular rhythm; no murmur |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Non-healing lesion of the left lower lip for about three months: a 1.2 cm firm, crusted ulcer on the vermilion that bleeds when touched, on a background of dry, scaly lips from years of outdoor work; no numbness of the lip or chin and no palpable neck nodes. Suspicious for squamous cell carcinoma; incisional biopsy taken today and otolaryngology consultation booked | resolved | confirmed | K13.0 | S — Synthetic presenting problem linked to his documented lip cancer; superseded by the biopsy diagnosis. |
| Chronic coronary disease with stable exertional angina: tightness in the chest when walking uphill or carrying loads for about a year, relieved by two or three minutes of rest, never at rest; heart attack eight years ago, treated in hospital, with no regular care or medicines since. Resting ECG: sinus rhythm with Q waves in the inferior leads. Synthetic modern episode linked to his documented heart attacks | active | confirmed | I25.119 | S — Synthetic modern coding of the documented heart disease. |
| Squamous cell carcinoma of the left lower lip (external vermilion): invasive, well-differentiated keratinizing squamous cell carcinoma on incisional biopsy; 1.2 cm, no palpable neck nodes; clinical stage T1 N0 (AJCC 8th edition, lip and oral cavity). Synthetic modern episode linked to his documented lip cancer | active | confirmed | C00.1 | S — Synthetic modern diagnosis; the cited sources do not record the type of his lip cancer. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Examination | Examination of the lips, mouth, and neck | Every 1 to 3 months in year 1, 2 to 6 months in year 2, 4 to 8 months in years 3 to 5, then yearly | Completed today | Scar healing; no nodularity; no neck nodes |
| Laboratory | Pathology: type, margins, depth of invasion, perineural and lymphovascular invasion | Full pathology after excision | Completed today | pT1, depth of invasion 2.5 mm, margins clear (closest 6 mm), no perineural or lymphovascular invasion |
| Imaging | Imaging of the primary site and neck | Before treatment as indicated; afterwards only for symptoms or findings | Up to date | Neck CT before surgery: no abnormal nodes; no routine imaging afterwards |
| Laboratory | TSH | Every 6 to 12 months only if the neck was irradiated | Not indicated | Neck not irradiated |
| Self-management | Sun protection of the lips and skin | Every visit | Completed today | Using lip balm with sunscreen and a hat |
| Self-management | Tobacco and alcohol use | Every visit | Completed today | Tobacco-free; alcohol one or two beers some weekends |
| Referral | Dental evaluation | After diagnosis, then routine | Due | Dental check-up advised; he will look into options |
| Examination | Blood pressure (goal below 130/80) | Every visit | Completed today | 128/78 |
| Examination | Weight, BMI, and physical activity | Every visit | Completed today | 93.0 kg, BMI 27.2 |
| Survey | Angina frequency and nitroglycerin use | Every visit | Completed today | None for four weeks; no nitroglycerin |
| Medication safety | Adherence and side effects: aspirin, high-intensity statin, beta-blocker | Every visit | Completed today | All taken daily; no muscle symptoms |
| Laboratory | Lipid panel | 4 to 12 weeks after starting or changing lipid therapy, then every 3 to 12 months; goal LDL below 55 mg/dL | Completed today | Five weeks after starting atorvastatin: total cholesterol 136, LDL 68, HDL 42, triglycerides 130 mg/dL; ezetimibe added |
| Laboratory | ALT on statin | Baseline; repeat only for symptoms | Completed today | 31 U/L |
| Referral | Cardiac rehabilitation | After a heart attack or for stable angina: up to 36 sessions | Referred | Starting this month, three sessions a week |
Goal progress:
Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Head and Neck Cancers (cancer of the lip and oral cavity) (2026); 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease (2023); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); CMID: Clinical Monitoring Intelligence Database, ischemic heart disease monograph (2026)
Follow-up: Cardiac rehabilitation three times a week. Visit in about ten weeks with a lipid panel and lip examination. Next scheduled visit 1951-09-21: coronary disease review in cardiac rehabilitation, lipid recheck after ezetimibe, and lip surveillance. [S]